The average one-year price target for aTyr Pharma (NASDAQCM:ATYR) (DB:471A) has been revised to $115.60 / share. This is an increase of 3,900.04% from the prior estimate of $2.89 dated October 20, 2026. These figures represent aggregate analyst targets collected by Fintel, rather